Full-Time

Senior Project Finance Analyst

Posted on 7/2/2025

Catalyst Clinical Research

Catalyst Clinical Research

201-500 employees

Provides customizable clinical research solutions

No salary listed

No H1B Sponsorship

United States

In Person

Category
đź’°Finance & Banking (1)
Requirements
  • Bachelor’s degree or equivalent level of educations required.
  • 4 to 6 years of relevant experience in operational/project finance role
  • Experience in invoicing, collections, and project analysis
  • Experience in revenue and cost recognition
  • Experience in project accounting
  • Background in Clinical Research
  • Proficient with Microsoft Office Suite
  • Excellent written and oral communication skills
  • Excellent presentation skills
  • Strong organizational, problem-solving, and analytical skills
  • Ability to manage priorities and workflow
  • Versatility, flexibility, and a willingness to work within constantly changing priorities
  • Proven ability to handle multiple projects and meet deadlines
  • Strong interpersonal skills
  • Ability to deal effectively with a diversity of individuals at all organizational levels
  • Commitment to excellence and high standards
  • Creative, flexible, and innovative team player
  • Ability to work independently and as a member of various teams and committees
  • Good judgement with the ability to make timely and sound decisions.
Responsibilities
  • Works directly with project leads to understand and report current project status to leadership.
  • Identifies issues related to contract amendments, values, or deliverables.
  • Analyzes operational project data as it pertains to relevant financial metrics for reporting on a monthly, quarterly, and annual basis.
  • Works with project leads to report revenue actuals and forecast.
  • Prepares and distributes monthly invoices and financial reporting packages to clients and internal leadership.
  • Performs account reconciliations for relevant project finance GL accounts.
  • Performs regular profitability and cash flow analyses on assigned projects.
  • Works with project leads to forecast contractor spend.
  • Set up all vendors and contractors in payment system including acquiring completed 1099.
  • Set up all vendors and contractors in the banking system including acquiring completed Direct Deposit form.
  • Manage Certify and prepare expense reports for payment/invoicing twice per month.
  • Create client specific time sheets as needed.
  • Work with Project Manager to develop system to determine when Investigator payments are earned and ready for payment.
  • Process payments to vendors, investigators and contractors as needed.
  • Prepare an actual to budget monthly by activity and distribute to designated team.
  • Work with Project Manager to determine the actual activities completed and compare to hours incurred by activity.
  • Prepare monthly invoices or by milestone as appropriate by project.
  • Prepare Change orders when needed.
  • Maintain filing system for accounts payable, contractor payments and invoices.
  • Contact contractors and clients as requested to obtain required documents.
  • Perform other tasks as requested by the company's CFO.
Catalyst Clinical Research

Catalyst Clinical Research

View

Catalyst Clinical Research provides tailored clinical research solutions for the biopharmaceutical industry. Their services are divided into two main offerings: Catalyst Flex, which focuses on multi-therapeutic global resourcing and functional services, and Catalyst Oncology, a full-service clinical research organization specializing in oncology. With a team of over 500 professionals across the US, UK, and Europe, Catalyst emphasizes a customer-centric approach, developed over more than a decade of feedback from clients. This approach allows them to create flexible solutions that meet the specific needs of their customers. Catalyst stands out from competitors by prioritizing a people-first culture, promoting a healthy work-life balance for its employees, and ensuring they have the resources needed for success. The company's goal is to drive effective clinical development studies while fostering a supportive environment for both clients and staff.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Wilmington, North Carolina

Founded

2013

Simplify Jobs

Simplify's Take

What believers are saying

  • Catalyst's inclusion in the Inc. 5000 highlights its rapid growth and market presence.
  • The rise of precision medicine aligns with Catalyst's focus on specialized oncology services.
  • Global expansion offers Catalyst access to diverse patient populations for clinical trials.

What critics are saying

  • Increased competition in oncology CRO market may impact Catalyst's market share.
  • Integration of Genpro Research may present cultural and operational alignment challenges.
  • Rapid growth could strain resources and lead to potential quality control issues.

What makes Catalyst Clinical Research unique

  • Catalyst offers customizable clinical research solutions through Catalyst Flex and Catalyst Oncology.
  • Catalyst's flexible service model is built on over a decade of customer feedback.
  • Catalyst Oncology collaborates with Imerman Angels to enhance cancer patient support.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

PR Newswire
Aug 19th, 2024
Catalyst Clinical Research Again Named One Of The Fastest-Growing Private Companies

CRO makes the list for the fifth consecutive yearWILMINGTON, N.C., Aug. 19, 2024 /PRNewswire/ -- Catalyst Clinical Research joined the 2024 Inc. 5000 list of the nation's fastest-growing private companies for its fifth consecutive year. This year Catalyst earned a spot at 2,740 with 185% growth during the past three years."We are honored to be recognized on the Inc. 5000, joining an incredible list of impressive companies. During a period of our global expansion, Catalyst continues to deliver high-quality clinical research services for our clients," says Nik Morton, President and CEO of Catalyst Clinical Research

PR Newswire
Aug 8th, 2024
Catalyst Clinical Research Announces First Cco

Kristin Judge assumes leadership role for all commercial functionsWILMINGTON, N.C., Aug. 8, 2024 /PRNewswire/ -- Catalyst Clinical Research announced today that Kristin Judge is its first chief commercial officer (CCO). She assumed the role on July 29, 2024, and leads the company's commercial functions.Kristin Judge, Chief Commercial Officer, Catalyst Clinical Research"Kristin has the depth of commercial experience to support Catalyst's continued growth," said Nik Morton, President and CEO of Catalyst Clinical Research. "Her experience supporting biotech, and pharmaceutical customers with CRO services and life-sciences technologies will be invaluable. She has embraced Catalyst's culture and vision for a differentiated CRO, and will ensure our commercial team is best positioned to deliver strengthened sales performance and continued growth.""Catalyst aligns directly with my strong belief that you can have a company with a positive team culture, people who care about each other, leaders who embrace authenticity, and staff who help customers and thousands of patients and families around the world. What could be better than that?" Ms

Contract Pharma
Aug 8th, 2024
Catalyst Clinical Research Names Chief Commercial Officer

Catalyst Clinical Research has named Kristin Judge as its first chief commercial officer (CCO).

PR Newswire
May 31st, 2024
Catalyst Oncology And Imerman Angels Announce Collaboration

Engagement coincides with National Cancer Survivors DayWILMINGTON, N.C., May 31, 2024 /PRNewswire/ -- Starting on June 2, National Cancer Survivors Day, Catalyst Oncology, the biotech-focused oncology CRO brand of Catalyst Clinical Research, will start a collaboration with Imerman Angels, a renowned nonprofit organization providing free, personalized one-on-one cancer support.Catalyst Oncology seeks to increase the visibility of the support and resources Imerman Angels makes available to cancer patients, survivors, and caregivers to ensure no one faces cancer alone."Catalyst is excited to collaborate with Imerman Angels, an organization that shares our dedication to improving the lives of those affected by cancer," said Keya Watkins, Senior Vice President, Catalyst Oncology. "This connection is a great reminder that we are part of a larger community that can make an impressive impact alongside Imerman Angels, which provides comprehensive support to patients and their families. This also reinforces Catalyst Oncology's commitment to help our innovative biotech clients develop therapies to support cancer patients.""We are looking forward to working with Catalyst Oncology," said Jonny Imerman, Co-founder and Chief Mission Officer, Imerman Angels. "Together, we can reach more individuals, provide more support, and make a greater impact in the cancer community."The collaboration will be marked at a private event on National Cancer Survivors Day, a day dedicated to honoring and celebrating cancer survivors, their families, and caregivers, which occurs during the American Society of Clinical Oncology (ASCO) annual conference in Chicago.About Catalyst OncologyCatalyst Oncology is a full-service, specialty clinical research organization (CRO) built to serve the global biotech industry. Backed by leading retention rates and a culture rooted in its core values, Catalyst Oncology provides customers with teams experienced across all functions, knowledgeable in complex drug classes and study designs, and with data-centric methodologies that help bring next-generation therapies to cancer patients.Catalyst Oncology is one of two established, branded solutions offered by Catalyst Clinical Research and employs more than 1,000 staff and several offices in the United States, Europe, and the Asia-Pacific region. Catalyst's flexible service model comes from more than a decade of listening to customers, devising customer-centric solutions, and helping customers advance clinical studies by leveraging expert teams and innovative technologies

PR Newswire
Feb 14th, 2024
Catalyst Clinical Research Announces Ceo Succession

Nik Morton brings decades of experience in clinical research with senior roles in global operations, digital clinical trials, biostatistics, site and patient accessWILMINGTON, N.C., Feb. 14, 2024 /PRNewswire/ -- Catalyst Clinical Research announces today that Nik Morton, the company's president and COO, assumed its CEO role on 12 February 2024. Mr. Morton joined Catalyst as its COO in 2022. Mr. Morton moved into his new position while Nick Dyer, Catalyst's former CEO, has shifted his focus to overseeing the strategic growth of the companies within Project Constellation Holdings, the parent company of Catalyst Clinical Research and Genpro Research.Nik Morton, CEO and President, Catalyst Clinical Research"Nik is an experienced clinical research executive and is uniquely qualified to assume this role," said Nick Dyer, Executive Chair for Project Constellation Holdings

INACTIVE